Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETANERCEPT Cause Diffuse large b-cell lymphoma? 97 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Diffuse large b-cell lymphoma have been filed in association with ETANERCEPT (ENBREL). This represents 0.0% of all adverse event reports for ETANERCEPT.

97
Reports of Diffuse large b-cell lymphoma with ETANERCEPT
0.0%
of all ETANERCEPT reports
8
Deaths
59
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From ETANERCEPT?

Of the 97 reports, 8 (8.2%) resulted in death, 59 (60.8%) required hospitalization, and 22 (22.7%) were considered life-threatening.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 97 reports have been filed with the FAERS database.

What Other Side Effects Does ETANERCEPT Cause?

Drug ineffective (60,367) Rheumatoid arthritis (33,166) Pain (31,961) Arthralgia (27,429) Injection site pain (24,717) Off label use (20,178) Fatigue (19,907) Joint swelling (18,462) Injection site erythema (17,736) Condition aggravated (15,897)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which ETANERCEPT Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

ETANERCEPT vs ETANERCEPT-SZZS ETANERCEPT vs ETELCALCETIDE ETANERCEPT vs ETEPLIRSEN ETANERCEPT vs ETESEVIMAB ETANERCEPT vs ETHACRYNIC ACID

Related Pages

ETANERCEPT Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma ETANERCEPT Demographics